Alexandria Real Estate Equities
ARE
#2299
Rank
โ‚น806.52 B
Marketcap
โ‚น4,628
Share price
1.09%
Change (1 day)
-18.45%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Revenue for Alexandria Real Estate Equities (ARE)

Revenue in 2026 (TTM): โ‚น255.04 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current revenue (TTM ) is โ‚น273.16 Billion. In 2025 the company made a revenue of โ‚น264.38 Billion an increase over the revenue in the year 2024 that were of โ‚น261.62 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alexandria Real Estate Equities from 1997 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น255.04 B-3.53%
2025 โ‚น264.38 B1.06%
2024 โ‚น261.62 B10.56%
2023 โ‚น236.63 B11.01%
2022 โ‚น213.16 B35.85%
2021 โ‚น156.91 B14.24%
2020 โ‚น137.36 B26.99%
2019 โ‚น108.16 B17.66%
2018 โ‚น91.93 B28.23%
2017 โ‚น71.69 B17.5%
2016 โ‚น61.01 B12.03%
2015 โ‚น54.46 B19.29%
2014 โ‚น45.65 B19.18%
2013 โ‚น38.30 B16.48%
2012 โ‚น32.88 B24.57%
2011 โ‚น26.40 B28.31%
2010 โ‚น20.57 B13.9%
2009 โ‚น18.06 B0.52%
2008 โ‚น17.97 B45.17%
2007 โ‚น12.37 B14.37%
2006 โ‚น10.82 B25.73%
2005 โ‚น8.60 B28.66%
2004 โ‚น6.69 B10.64%
2003 โ‚น6.04 B7.66%
2002 โ‚น5.61 B18.01%
2001 โ‚น4.76 B25.75%
2000 โ‚น3.78 B30.96%
1999 โ‚น2.89 B44.66%
1998 โ‚น1.99 B82.92%
1997 โ‚น1.09 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚น6.057 T 2,117.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น6.912 T 2,430.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.561 T 1,203.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.816 T 931.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น420.32 B 53.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.638 T 1,598.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น410.17 B 50.15%๐Ÿ‡บ๐Ÿ‡ธ USA